Pharmacological enhancement of slow-wave activity improves cognition and reduces amyloidosis at an early stage in a mouse model of Alzheimer's disease
Sedef Kollarik, Dorita Bimbiryte, Aakriti Sethi, Inês Dias, Carlos G. Moreira, Daniela Noaín
This study shows that enhancing slow-wave activity through sodium oxybate in early-stage Alzheimer's mice improves cognition and reduces amyloidosis, but not in older mice.
bioRxiv · Oct 2, 2024 · PreprintNeuroscience